HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

NASDAQ:HOOK

Overview | Financials
Company Name HOOKIPA Pharma Inc.
Symbol HOOK
Currency USD
Price 3.76
Market Cap 45,325,067
Dividend Yield 0%
52-week-range 3.415 - 11.3
Industry Biotechnology
Sector Healthcare
CEO Mr. Joern Aldag
Website https://www.hookipapharma.com

An error occurred while fetching data.

About HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead

Related Stocks

Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc.

PBYI

2.95 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.65 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

7.54 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

1.44 USD

PAVmed Inc. logo

PAVmed Inc.

PAVM

1.05 USD

Cytosorbents Corporation logo

Cytosorbents Corporation

CTSO

0.871 USD

Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

LUCD

0.938 USD

Tabula Rasa HealthCare, Inc. logo

Tabula Rasa HealthCare, Inc.

TRHC

10.5 USD

Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc.

CAPR

18.595 USD

Financials

Numbers are in millions USD

Numbers are in millions USD